Literature DB >> 1613363

Nasal septal haematoma in Nigeria.

A B Chukuezi1.   

Abstract

A prospective study of 46 consecutive patients with nasal septal haematoma admitted at the General Hospital, Owerri, Nigeria over a five year period is presented. The disease was commoner in males than females. The majority of the cases (65.6 per cent) were of unknown cause and were therefore grouped as spontaneous haematoma while 30.4 per cent were due to trauma. Trauma was more common in patients below the age of 15 years while spontaneous haematoma was common in patients above that age. All the patients with septal haematoma represented 0.2 per cent of total attendances to the ENT clinic over the period. Most of the patients presented with severe and threatening symptoms necessitating intense aggressive management. All the patients were managed by surgical incision and drainage, four had marked nasal abnormalities. Three patients died from a brain abscess as a complication of infected haematoma.

Entities:  

Mesh:

Year:  1992        PMID: 1613363     DOI: 10.1017/s0022215100119656

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  4 in total

1.  Nasal septal abscess in patients with immunosuppression.

Authors:  J M Debnam; A M Gillenwater; L E Ginsberg
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-28       Impact factor: 3.825

2.  Recurrent Nasal Septal Hematoma and Abscess: A Rare Manifestation of Leukemia.

Authors:  Chow Xiao Hong; Salina Husain; Aneeza Khairiyah Wan Hamizan; Farah Dayana Zahedi
Journal:  Clin Med Res       Date:  2021-02-13

3.  Innovative management of nasal septal hematoma in an infant.

Authors:  R Sumitha; Ajay Kumar Anandan; Aberna Govarthanaraj
Journal:  J Pharm Bioallied Sci       Date:  2015-04

4.  Nasalseptal hematoma/abscess: management and outcome in a tertiary hospital of a developing country.

Authors:  Jones N Nwosu; Peter C Nnadede
Journal:  Patient Prefer Adherence       Date:  2015-07-28       Impact factor: 2.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.